Last reviewed · How we verify

NCT05369325

Non-invasive Hemoglobin Monitoring in Outpatient Total Joint Arthroplasty

Completed Last updated 27 July 2023
What this trial tests

trial in Total Joint Arthroplasty in 200 participants. Completed in 1 July 2023.

Timeline
15 June 2022
Primary endpoint
1 July 2023
1 July 2023

Quick facts

Lead sponsorMayo Clinic
StatusCompleted
Study typeOBSERVATIONAL
Enrollment200
Start date15 June 2022
Primary completion1 July 2023
Estimated completion1 July 2023
Sites1 location across United States

Conditions studied

Sponsor

Mayo Clinic

Who can join

18 and older, any sex, with Total Joint Arthroplasty. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research is being done to better understand the accuracy of noninvasive hemoglobin tests on patients that recently underwent total joint arthroplasty.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05369325.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing